Search Results for 'embolic prevention'
-
InspireMD's CEO Steps Down
New CEO Marvin Slosman, a life sciences industry veteran, joins InspireMD from Integra LifeSciences.GlobeNewswire 12.11.19
-
InspireMD Receives Australian Regulatory Approval of CGuard Embolic Prevention System
Company is immediately launching the product with its local distribution partner.Globe Newswire 01.17.19
-
InspireMD Announces Regulatory Approval of CGuard Embolic Prevention System in Mexico
Commercial launch occurring immediately.Globe Newswire 10.26.18
-
Cardiovascular
InspireMD Issued Two New U.S. Patents
New issuances cover proprietary MicroNet Stent Jacket and related drug-eluting technology.Globe Newswire 10.17.18
-
Cardiovascular
InspireMD Receives Regulatory Approval for CGuard EPS, MGuard Prime in Ecuador
Approval is expected to enhance the company’s Latin American footprint.Globe Newswire 06.27.18
-
InspireMD Announces Regulatory Approval to Commercialize CGuard EPS and MGuard in Vietnam
Both products are now being sold in a variety of markets across Europe, Middle East, Asia and Latin America.Globe Newswire 06.04.18
-
Cardiovascular
First Patient Treated With InspireMD's CGuard EPS in India
Device used to treat patient with severe stenosis, calcification and thrombosis.Globe Newswire 04.03.18
-
Cardiovascular
InspireMD Forges Distribution, Sales and Marketing Agreement for CGuard EPS in South Korea
Solvit Medical to fund all regulatory, registration and reimbursement submissions.Globe Newswire 03.20.18
-
InspireMD Receives Indian Regulatory Approval of CGuard EPS
Company also signs agreement with medical device distributor in India.Globe Newswire 01.26.18
